Drugs

Exam Prep

Glossary

Handouts

SchoolsNew

Contact Lenses Medications Glossary Calculators Handouts Exam Prep

Disclaimer Privacy Policy Terms of Use Contact

Educational resource only — not medical advice. Independent study tool, not affiliated with or endorsed by the NBEO®. See our Disclaimer.

Medications›Antiglaucoma›iDose TR

iDose® TR

GoodRx

Travoprost 75 mcg · intracameral implant

Antiglaucoma, Injections & Implants

Approved uses

Open-angle glaucoma or ocular hypertension

A single travoprost implant administered intracamerally under aseptic conditions

Removes the daily-drop adherence problem for a prostaglandin, which is the usual reason pressure control fails

Contraindications

Ocular or periocular infections Corneal endothelial dystrophy Prior corneal transplantation Hypersensitivity.

Available Forms

Travoprost intracameral implant pre-loaded in a sterile single-dose inserter.

Mechanism of Action

Travoprost free acid, a prostaglandin analog is a selective FP prostanoid receptor agonist, which is believed to reduce IOP by increasing uveoscleral outflow. The exact mechanism of action is unknown at this time.

Warnings & Precautions

Iridocorneal angles: use with caution in narrow angles or other angle abnormalities.
Device dislocation: monitor routinely to confirm the implant remains at the site of administration.

Other forms of Travoprost

Travatan Z®
Travatan®

Other Antiglaucoma, Injections & Implants drugs

Actemra®
Alphagan-P®
Avastin®
Azopt®
Beovu®
Betagan®
Betoptic-S®
Botox®

Browse all medications All Antiglaucoma drugs All Injections & Implants drugs

Corneal adverse reactions, including corneal endothelial cell loss, have been reported.

May cause increased brown pigmentation of the iris, which is likely to be permanent.

Common Side Effects

the most common ocular adverse reactions reported in 2% to 6% of patients were increases in intraocular pressure, iritis, dry eye, and visual field defects.

Pregnancy & Lactation

Pregnancy: No adequate and well-controlled studies in pregnant women. Subcutaneous travoprost in animals produced adverse effects at exposures far above the clinical one.

Lactation: Unknown whether travoprost is present in human milk.

Pediatric Use

The safety and effectiveness of iDose TR have not been established in pediatric patients.

iDose TR (Travoprost 75 mcg) | EyeKnow O.D.